(Press-News.org) Can an individual's state of mind effect how well a vaccine may work? In the case of seniors and shingles, the answer is yes.
Reporting in the current online edition of the journal Clinical Infectious Diseases, Dr. Michael Irwin, a professor of psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA, demonstrates a link between untreated depression in older adults and decreased effectiveness of the herpes zoster —or shingles — vaccine.
Shingles is a painful, blistering skin rash that can last for months or even years. It's caused by the varicella–zoster virus, the same virus that causes chickenpox. It's thought to strike more than a million people over the age of 60 each year in the U.S.
Every year, health officials urge individuals 50 and older to get vaccinated against the virus. The vaccine boosts cell-mediated immunity to the virus and can decrease the incidence and severity of the condition.
But in a two-year study, Irwin, the first author of the research and director of the UCLA Cousins Center for Psychoneuroimmunology, and his colleagues measured immune responses to the shingles vaccination among 40 people aged 60 or older who suffered from a major depressive disorder and compared these responses to similar levels in 52 control patients matched by age and gender. Measurements were taken at the beginning of the study, and then at six weeks, one year and two years after the patients received either the shingles vaccine or a placebo.
Depressed patients not being treated with antidepressants showed a weaker immune response to the varicella–zoster virus — and thus were less able to respond to the shingles vaccine — than patients who were not depressed and patients who suffered from depression but werereceiving treatment with antidepressants.
The findings suggest that patients with untreated depression were "poorly protected by the shingles vaccination," Irwin said.
Surprisingly, when the depression was being treated, responses to the vaccine were normalized, even when the depression treatment had not been effective in lessening the symptoms of depression.
"Among depressed elderly, treatment with an antidepressant medication such as a selective serotonin uptake inhibitor might increase the protective effects of zoster vaccine," said Irwin.
Larger studies are needed to evaluate the possible relationship between untreated depression and the risk of shingles, the study noted, along with further research to establish what mechanisms are responsible for patients' reduced immune response.
And there is a clinical side as well, Irwin noted. "Efforts are also needed to identify and diagnose depressed elderly patients who might benefit from either a more potent vaccine or a multi-dose vaccination schedule." he said.
The findings have important public health implications beyond the prevention of shingles, possibly extending to other infectious diseases, Irwin said. Because this study measured immune system T cells that were specific to the varicella–zoster virus, the association may extend to T cells specific for antigens of other pathogens that cause disease in older adults, such as influenza.
If so, Irwin said, this suggests that untreated depression may identify a sub-group of elderly likely to respond poorly to other vaccines.
"While we know that psychological stress is associated with a weakened immune response to influenza vaccines in older adults, few studies have examined the association between depression and infectious disease risk, or disease-relevant immunologic endpoints, such as vaccine responses," he said.
###
There were multiple authors on the study. Other UCLA authors were Richard Olmstead and Carmen Carrillo. Please see the study for all authors and for conflict-of-interest statements.
Funding for the study was provided by the National Institute of Mental Health at the National Institutes of Health (R01-MH 55253) and, in part, by the Department of Veterans Affairs; a grant from Merck and Co. Inc.; National Institutes of Health grants R01-AG034588, R01-AG026364, R01-CA119159, R01-HL079955, R01 HL095799 and P30-AG028748; UCLA CTSI UL1TR000124; the Cousins Center for Psychoneuroimmunology; and the James R. and Jesse V. Scott Fund for Shingles Research.
The Cousins Center for Psychoneuroimmunology at UCLA encompasses an interdisciplinary network of scientists working to advance the understanding of psychoneuroimmunology by linking basic and clinical research programs and by translating findings into clinical practice. The center is affiliated with the Semel Institute for Neuroscience and Human Behavior at UCLA and the David Geffen School of Medicine at UCLA.
For more news, visit the UCLA Newsroom and follow us on Twitter.
UCLA study suggests link between untreated depression, response to shingles vaccine
2013-02-20
ELSE PRESS RELEASES FROM THIS DATE:
BUSM authors propose potential epigenetic mechanisms for improved cancer therapy
2013-02-20
(Boston) – A review article by researchers at Boston University School of Medicine (BUSM) proposes a new epigenetic hypothesis linked to tumor production and novel ideas about what causes progenitor cells to develop into cancer cells. Published in the February 2013 issue of Epigenomics, the article provides examples of how epigenetic drug treatments could be beneficial in treating cancers while also decreasing the likelihood of cancer relapse.
The article was written by researchers at the Boston University Cancer Center. Sibaji Sarkar, PhD, adjunct instructor of medicine ...
Infants in poverty show different physiological vulnerabilities to the care-giving environment
2013-02-20
Some infants raised in poverty exhibit physical traits that make them more vulnerable to poor caregiving, according to new research published in Psychological Science, a journal of the Association for Psychological Science. The combination of physiological vulnerability and poor caregiving may lead these children to show increased problem behaviors later in childhood.
For infants growing up in poverty, the ability to adapt and regulate — both biologically and behaviorally — in response to various environmental pressures seems to be critical for successful development.
To ...
Rewriting a receptor's role
2013-02-20
In a pair of new papers, researchers at the University of California, San Diego School of Medicine and the Royal Netherlands Academy of Arts and Sciences upend a long-held view about the basic functioning of a key receptor molecule involved in signaling between neurons, and describe how a compound linked to Alzheimer's disease impacts that receptor and weakens synaptic connections between brain cells.
The findings are published in the Feb. 18 early edition of the Proceedings of the National Academy of Sciences.
Long the object of study, the NMDA receptor is located ...
IU research: Rock-paper-scissors a parable for cycles in finance, fashion, politics and more
2013-02-20
BLOOMINGTON, Ind. -- Using a grown-up version of the rock-paper-scissors game, Indiana University cognitive scientists offer a new theory of the group dynamics that arise in situations as varied as cycles of fashion, fluctuations of financial markets, eBay bidding wars and political campaign strategies.
In a study written about this week in PLOS ONE, the researchers analyzed situations in which each person's decision depends on what they think other people will decide, looking at the riddle of "what you think I think you think I think."
What they found, said Seth Frey, ...
New compound holds high promise in battling kidney cancer
2013-02-20
RIVERSIDE, Calif. — Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer.
Named TIR-199, the compound targets the "proteasome," a cellular complex in kidney cancer cells, similar to the way the drug bortezomib, approved by the Food and Drug Administration, targets and inhibits the proteasome in multiple myeloma cells, a cancer coming from bone marrow.
Michael Pirrung, a distinguished professor of chemistry at UC Riverside, announced the development of TIR-199 in a lecture ...
Diagnosis and treatment now possible for osteoarthritic cats
2013-02-20
VIDEO:
Scientists at the University of Montreal's Quebec Research Group in Animal Pharmacology have found a way to recognize and treat osteoarthritis in cats -- a condition that the owner might...
Click here for more information.
Scientists at the University of Montreal's Quebec Research Group in Animal Pharmacology have found a way to recognize and treat osteoarthritis in cats – a condition that the owner might not notice and that can make even petting painful. "Osteoarthritis ...
Stanford researchers develop tool for reading the minds of mice
2013-02-20
If you want to read a mouse's mind, it takes some fluorescent protein and a tiny microscope implanted in the rodent's head.
Stanford scientists have demonstrated a technique for observing hundreds of neurons firing in the brain of a live mouse, in real time, and have linked that activity to long-term information storage. The unprecedented work could provide a useful tool for studying new therapies for neurodegenerative diseases such as Alzheimer's.
The researchers first used a gene therapy approach to cause the mouse's neurons to express a green fluorescent protein ...
That's the way the droplets adhere
2013-02-20
CAMBRIDGE, MA -- Understanding exactly how droplets and bubbles stick to surfaces — everything from dew on blades of grass to the water droplets that form on condensing coils after steam drives a turbine in a power plant — is a "100-year-old problem" that has eluded experimental answers, says MIT's Kripa Varanasi. Furthermore, it's a question with implications for everything from how to improve power-plant efficiency to how to reduce fogging on windshields.
Now this longstanding problem has finally been licked, Varanasi says, in research he conducted with graduate student ...
Artful science
2013-02-20
There are "things hidden in plain sight" all around us. But art can help students see their world anew, unlocking discoveries in fields ranging from plant biology to biomedical imaging, according to University of Delaware professor John Jungck.
Jungck's sentiments were echoed by a panel of experts speaking on "Artful Science" on Feb. 15 at the annual meeting of the American Association for the Advancement of Science (AAAS) in Boston. Jungck organized the panel and also spoke at the event.
Canoeing on a lake near his home in northwestern Minnesota when he was a youngster, ...
Powerful people are looking out for their future selves
2013-02-20
Would you prefer $120 today or $154 in one year? Your answer may depend on how powerful you feel, according to new research in Psychological Science, a journal of the Association for Psychological Science.
Many people tend to forego the larger reward and opt for the $120 now, a phenomenon known as temporal discounting. But research conducted by Priyanka Joshi and Nathanael Fast of the University of Southern California Marshall School of Business suggests that people who feel powerful are more likely to wait for the bigger reward, in part because they feel a stronger connection ...